JP Morgan Knock-Out DAX/ DE000JX53XB7 /
11/06/2024 13:20:08 | Chg.+1.66 | Bid13:21:23 | Demandez à13:21:23 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
91.51EUR | +1.85% | 91.55 Bid taille: 100,000 |
91.56 Ask la taille: 100,000 |
DAX | 27,522.80 - | 31/12/2078 | Put |
GlobeNewswire
13:31
HUM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Human...
GlobeNewswire
13:30
Sonder Holdings Inc. Announces Amendment to Financing Agreement and Provides Update on Portfolio Opt...
GlobeNewswire
13:30
Agrify Corporation Announces $500K Turnkey Extraction Equipment Deal with Grotech Farms LLC in Bridg...
GlobeNewswire
13:18
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Clas...
GlobeNewswire
13:15
AppTech Payments Announces Strategic Partnership with FISB Solutions to Upgrade Legacy Banking Syste...
GlobeNewswire
13:05
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
GlobeNewswire
13:05
Banks are making climate commitments, but are they actually making a difference?
GlobeNewswire
13:03
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectiv...
GlobeNewswire
13:00
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil
GlobeNewswire
13:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...
GlobeNewswire
13:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2...
GlobeNewswire
13:00
Republic enhances tokenized asset accessibility with Zero Hash's fiat and USDC payment rails
GlobeNewswire
13:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule ...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page